Facebook
Twitter
LinkedIn
Forward
Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.
|
Daniel Richardson, MD, MA, MSc, will explore best practices to approach the care of older adults with leukemia. He will also discuss novel therapeutic options for patients with acute lymphoblastic and acute myeloid leukemia alongside practical considerations to approach shared decision-making.
|
Katherine Garman, MD, and Meira Epplein, PhD, will provide information on gastric cancer and important risk factors such as H. pylori infection. We will describe some of the racial disparities associated with gastric cancer in the US, highlighting those that are relevant for North Carolina. We will also discuss H. pylori as a modifiable risk factor and we will review current guidelines on H. pylori testing, treatment, eradication testing, and the growing problem of antibiotic resistance.
|
Noelle Robertson, MD, CAQSM presents an evidence-based review of outpatient primary care screening for breast, colon, lung and prostate cancer.
|
Cellular therapy as a form of immunotherapy is a rapidly growing field for a variety of diseases. Brianne Buchanan, PA-C, will survey some of the latest research involving CAR-T and similar cellular therapies that can go from the bench to the bedside. She will also describe the wide range of cellular therapy options available to consider these for patients.
|
Matthew I. Milowsky, MD, FASCO, presents on "Update in Bladder Cancer"
|
Kevin Chen, PharmD, MS, BCOP, CPP, presents on "Antibody-Drug Conjugates in Oncology: From Bench to Bedside."
|
Michael Galgano, MD, FAANS, will focus on differentiating the various types of spinal tumors, ranging from metastases, to primary vertebral column tumors, and intradural spinal cord tumors. He will discus the contributions of co-morbidities and frailty on the management of patients with spinal tumors. He will also aim to give the audience a brief exposure to the surgical management of spinal oncology, and what is entailed to execute robust local control.
|
This seminar will review the causes, risk factors, pathophysiology, clinical presentation, and possible treatment options for medication-related osteonecrosis of the jaws as it relates to cancer patients. It will also include strategies to decrease the risk of developing this debilitating condition.
|
Anne W. Beaven, MD, will review recent updates and evolving standard of care for management of Hodgkin and Non-Hodgkin lymphoma.
|